Literature DB >> 7718088

Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?

H Valdimarsson1, B S Baker, I Jónsdóttir, A Powles, L Fry.   

Abstract

Psoriasis is a T-cell-mediated disease that can be triggered by infection with group A beta-haemolytic streptococci. It is proposed that psoriatic skin lesions are initiated by exotoxin-activated T cells, and persist because of specific T cells that react both with streptococcal M protein and a skin determinant, possibly a variant of keratin. As discussed here by Helgi Valdimarsson and colleagues, cytokines released by the superantigen (SAg)-stimulated T cells could induce or enhance the expression of the crossreactive autoantigen, leading to the rescue and activation of autoreactive T cells. In this way, the SAg-determined T-cell receptor V beta phenotype would be maintained by T cells in psoriatic lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7718088     DOI: 10.1016/0167-5699(95)80132-4

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  49 in total

Review 1.  Skin innate immune system in psoriasis: friend or foe?

Authors:  B J Nickoloff
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  Contradictory Concepts in the Etiology and Regression of Kaposi's Sarcoma. The Ferenc Györkey Memorial Lecture.

Authors:  Joseph G Sinkovics
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

3.  A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting.

Authors:  Ari Karason; Johann E Gudjonsson; Ruchi Upmanyu; Arna A Antonsdottir; Valdimar B Hauksson; E Hjaltey Runasdottir; Hjortur H Jonsson; Daniel F Gudbjartsson; Michael L Frigge; Augustine Kong; Kari Stefansson; Helgi Valdimarsson; Jeffrey R Gulcher
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

4.  Reduced IFN-gamma responses associated with HLA-DR15 presentation of streptococcal cell wall proteins to dermal Th-1 cells in psoriasis.

Authors:  Barbara S Baker; Jean-Marc Ovigne; Vincent A Fischetti; Anne Powles; Lionel Fry
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

Review 5.  Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

Authors:  Brian J Nickoloff; Frank O Nestle
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

6.  Development of new-onset psoriasis while on anti-TNFalpha treatment.

Authors:  C Matthews; S Rogers; O FitzGerald
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

7.  The Psoriasis Risk Allele HLA-C*06:02 Shows Evidence of Association with Chronic or Recurrent Streptococcal Tonsillitis.

Authors:  Karita Haapasalo; Lotta L E Koskinen; Jari Suvilehto; Pekka Jousilahti; Annika Wolin; Sari Suomela; Richard Trembath; Jonathan Barker; Jaana Vuopio; Juha Kere; T Sakari Jokiranta; Päivi Saavalainen
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

8.  Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome.

Authors:  S Sano; Y Matsui; S Itami; K Yoshikawa
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

9.  HLA-Cw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: A prospective case series.

Authors:  Ragna H Thorleifsdottir; Sigrun L Sigurdardottir; Bardur Sigurgeirsson; Jon H Olafsson; Hannes Petersen; Martin I Sigurdsson; Johann E Gudjonsson; Andrew Johnston; Helgi Valdimarsson
Journal:  J Am Acad Dermatol       Date:  2016-08-09       Impact factor: 11.527

Review 10.  Psoriasis: a complex clinical and genetic disorder.

Authors:  Helgi Valdimarsson; Ari Karason; Johann E Gudjonsson
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.